BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Sabre//Sabre VObject 4.5.8//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Zurich
X-LIC-LOCATION:Europe/Zurich
TZURL:http://tzurl.org/zoneinfo/Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19961027T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:news1615@biomedizin.unibas.ch
DTSTAMP;TZID=Europe/Zurich:20260217T153805
DTSTART;TZID=Europe/Zurich:20260317T121500
SUMMARY:FARO Seminar in Oncology
DESCRIPTION:1. Bardha Citaku: “Cancer Surveillance and Risk-Reducing Surg
 eries in Hereditary Breast and Ovarian Cancer and Lynch Syndrome: Findings
  from the Swiss\, Korean\, and Israeli CASCADE cohorts”\\r\\n2. Massimo 
 Andreis: “A CRISPR-Cas9 knockout screen to uncover metabolic drivers of 
 anti-leukemia immunity”
X-ALT-DESC:<p>1. Bardha Citaku: “Cancer Surveillance and Risk-Reducing Su
 rgeries in Hereditary Breast and Ovarian Cancer and Lynch Syndrome: Findin
 gs from the Swiss\, Korean\, and Israeli CASCADE cohorts”</p>\n<p><br />
 2. Massimo Andreis: “A CRISPR-Cas9 knockout screen to uncover metabolic 
 drivers of anti-leukemia immunity”</p>\n\n
DTEND;TZID=Europe/Zurich:20260317T131500
END:VEVENT
END:VCALENDAR
